Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy
Completed · Phase 2 · Has a placebo group
Conditions studied: Type 2 Diabetes Mellitus
In brief
The purpose of this study is to evaluate the safety and efficacy of S-707106 co-administered with metformin in subjects with type 2 diabetes mellitus.
Key facts
- Study ID
- NCT01240759
- Run by
- Shionogi
- People needed
- 218
- Starts
- 2010-10-01
- Expected to finish
- 2012-01-01
- Last updated by the study team
- 2018-05-15
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Juno Research, LLC — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.